MedTrace Logo

Exercise Resistance in Type 2 Diabetes

NCT01911104 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2026-03-30

No results posted yet for this study

Summary

The purpose of this study is to collect data to help researchers identify factors that prevent certain individuals from receiving the beneficial effects of exercise.

Conditions

Interventions

BEHAVIORAL

Exercise

10 weeks of aerobic exercise

Sponsors & Collaborators

Principal Investigators

  • Lauren M Sparks, PhD · Translational Research Institute for Metabolism and Diabetes

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-06-15
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01911104 on ClinicalTrials.gov